CLS2901C
/ CellSeed
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 10, 2026
A Phase III Study of CLS2901C in Patients With Osteoarthritis of the Knee
(clinicaltrials.gov)
- P3 | N=96 | Recruiting | Sponsor: CellSeed Inc. | Trial primary completion date: Jul 2027 ➔ Dec 2028
Trial primary completion date • Immunology • Osteoarthritis • Rheumatology
August 12, 2024
A Phase III Study of CLS2901C in Patients With Osteoarthritis of the Knee
(clinicaltrials.gov)
- P3 | N=96 | Recruiting | Sponsor: CellSeed Inc.
New P3 trial • Immunology • Osteoarthritis • Pain • Rheumatology
1 to 2
Of
2
Go to page
1